Akebia Therapeutics (AKBA) Gross Margin Growth (3y) (2021 - 2026)
Akebia Therapeutics (AKBA) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Akebia Therapeutics | 244.72 Mn | 89.17 Mn | 38.70 Mn | 944.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 944.00 |
| Mar 31, 2026 | 499.00 |
| Dec 31, 2025 | 2,056.00 |
| Sep 30, 2025 | 6,262.00 |
| Jun 30, 2025 | -116.00 |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | -3,204.00 |
| Sep 30, 2024 | 46.00 |
| Jun 30, 2024 | 4,312.00 |
| Mar 31, 2024 | 1,334.00 |
| Dec 31, 2023 | 26,901.00 |
| Sep 30, 2023 | 15,947.00 |
| Jun 30, 2023 | 16,305.00 |
| Mar 31, 2023 | 338.00 |
| Dec 31, 2022 | 8,962.00 |
| Sep 30, 2022 | 30,405.00 |
| Jun 30, 2022 | 11,478.00 |
| Mar 31, 2022 | -3.03 Mn |
| Dec 31, 2021 | 2,227.00 |